DE4CC0DE-5FC3-4494-BCBF-4D50B00366B5

Johnson & Johnson 2019 Revenue Forecast Misses Expectations

By Dayeeta Das
Share this article
Johnson & Johnson 2019 Revenue Forecast Misses Expectations

Johnson & Johnson on Tuesday forecast 2019 sales that fell short of analysts' estimates after reporting better-than- expected fourth-quarter profit and revenue.

The company said it expects 2019 sales in the range of $80.4 billion to $81.2 billion, compared with the average analyst estimate of $82.69 billion, according to IBES data from Refinitiv.

Overall fourth-quarter sales rose to $20.39 billion from $20.20 billion, also topping the Wall Street estimate of $20.20 billion.

Pharmaceuticals sales rose 5.3% to $10.19 billion in the fourth quarter, led by Crohn's disease treatment Stelara. Analysts had expected revenue of $10.08 billion for the unit.

Net Profit

The company posted net profit of $3.04 billion, or $1.12 per share, for the fourth quarter, compared with a loss of $10.71 billion, or $3.99 per share, a year earlier, when it recorded a $13.6 billion charge related to changes to the US tax law.

ADVERTISEMENT

Excluding items, the company earned $1.97 per share, beating analysts' average estimate of $1.95 per share.

The company said it expected adjusted 2019 profit in the range of $8.50 per share to $8.65 per share, compared with analysts' expectation of $8.60 per share.

News by Reuters, edited by ESM. Click subscribe to sign up to ESM: European Supermarket Magazine.

Get the week's top grocery retail news

The most important stories from European grocery retail direct to your inbox every Thursday

Processing your request...

Thanks! please check your email to confirm your subscription.

By signing up you are agreeing to our terms & conditions and privacy policy. You can unsubscribe at any time.